Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease

被引：0
|
作者：
Fueller, D. [1 ]
Liu, C. [1 ]
Ko, Y. -A. [1 ]
Alkhoder, A. [1 ]
Desai, S. R. [1 ]
Almuwaqqat, Z. [1 ]
Patel, S. A. [1 ]
Ejaz, K. [1 ]
Kauser, T. [1 ]
Martini, A. [1 ]
Alvi, Z. [1 ]
Mehta, P. K. [1 ]
Sperling, L. S. [1 ]
Quyyumi, A. A. [1 ]
机构：
[1] Emory Clin Cardiovasc Res Inst, Atlanta, GA USA
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Significance of Soluble Urokinase-type Plasminogen Activator Receptor in Patients with Coronary Heart Disease
    Zheng, Zhenda
    Cheng, Cailian
    Liu, Dinghui
    Song, Zhiming
    Chen, Lin
    Qian, Xiaoxian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C144 - C144
  • [42] SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) SERUM LEVELS PREDICT PROGRESSION OF KIDNEY DISEASE IN CHILDREN
    Schaefer, Franz
    Wuehl, Elke
    Trachtman, Howard
    Kirchner, Marietta
    Hayek, Salim S.
    Anarat, Ali
    Duzova, Ali
    Mir, Sevgi
    Paripovic, Dusan
    Yilmaz, Alev
    Lugani, Francesca
    Arbeiter, Klaus
    Reiser, Jochen
    PEDIATRIC NEPHROLOGY, 2017, 32 (09) : 1652 - 1652
  • [43] Soluble urokinase plasminogen activator receptor (suPAR) is an independent risk factor for stroke in patients with atrial fibrillation
    Westin, O.
    Rasmussen, L. J. H.
    Andersen, O.
    Eugen-Olsen, J.
    Friberg, J.
    EUROPEAN HEART JOURNAL, 2018, 39 : 406 - 406
  • [44] The role of the soluble urokinase plasminogen activator (suPAR) in children with pneumonia
    Wrotek, A.
    Jackowska, T.
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2015, 209 : 120 - 123
  • [45] Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission
    Toldi, Gergely
    Beko, Gabriella
    Kadar, Gabriella
    Macsai, Emilia
    Kovacs, Laszlo
    Vasarhelyi, Barna
    Balog, Attila
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2013, 51 (02) : 327 - 332
  • [46] Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus
    Toldi, Gergely
    Szalay, Balazs
    Beko, Gabriella
    Bocskai, Marta
    Deak, Magdolna
    Kovacs, Laszlo
    Vasarhelyi, Barna
    Balog, Attila
    BIOMARKERS, 2012, 17 (08) : 758 - 763
  • [47] Prognostic value of soluble urokinase plasminogen activator receptor (suPAR) in patients admitted with acute heart failure
    Kandiah, A.
    Taraldsen, I
    El-Sheikh, M.
    El Caidi, N. Olsen
    Wisborg, F. Dencker
    Hove, J. Dahlgaard
    Grand, J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [48] Soluble urokinase plasminogen activator receptor (suPAR) predicts 1 year mortality in patients with acute breathlessness
    Chew-Harris, J. S.
    Appleby, S.
    Richards, A. M.
    Troughton, R. W.
    Pemberton, C. J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1573 - 1573
  • [49] Soluble urokinase plasminogen activator receptor (suPAR) as a novel biomarker in patients undergoing resection of pancreatic adenocarcinoma
    Loosen, Sven H.
    Binneboesel, Marcel
    Longerich, Thomas
    Roderburg, Christoph
    Trautwein, Christian
    Neumann, Ulf Peter
    Luedde, Tom
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [50] Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
    Manfredi, Mariangela
    Van Hoovels, Lieve
    Benucci, Maurizio
    De Luca, Riccardo
    Coccia, Carmela
    Bernardini, Pamela
    Russo, Edda
    Amedei, Amedeo
    Guiducci, Serena
    Grossi, Valentina
    Bossuyt, Xavier
    Perricone, Carlo
    Infantino, Maria
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (04):
12345